UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050903
Receipt number R000058013
Scientific Title The effect of telerehabilitation for patients with type 2 diabetes on the risk of cardiac disease
Date of disclosure of the study information 2023/05/01
Last modified on 2023/04/21 16:43:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of telerehabilitation for patients with type 2 diabetes on the risk of cardiac disease

Acronym

Effect of telerehabilitation for patients with type 2 diabetes

Scientific Title

The effect of telerehabilitation for patients with type 2 diabetes on the risk of cardiac disease

Scientific Title:Acronym

Effect of telerehabilitation for patients with type 2 diabetes

Region

Japan


Condition

Condition

patients with type 2 diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

the purpose of this study is to examine the effect of telerehabilitation for patients with type 2 diabetes, on the risk of cardiac disease and to determine the usefulness of telerehabilitation.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cardiac disease incident followed up 1 year after telerehabilitation

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

standard exercise instruction + telerehabilitation

Interventions/Control_2

standard exercise instruction

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Patients with type 2 diabetes
2. Outpatients

Key exclusion criteria

1. age < 20 years
2. Patients with Gait disturbance
3. Patients with severe musculoskeletal symptoms
4. Patinets with diabetes foot or lower extremity amputation
5. Patients with cognitive impairment
6. Patients contraindications to exercise training
7. Patients unable to consent

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Takeki
Middle name
Last name Ishida

Organization

School of Health Sciences at Narita, International University of Health and Welfare

Division name

Department of Physical Therapy

Zip code

286-8686

Address

4-3 Kozunomori, Narita city, Chiba, Japan

TEL

0476-20-7717

Email

takekii@iuhw.ac.jp


Public contact

Name of contact person

1st name Takeki
Middle name
Last name Ishida

Organization

School of Health Sciences at Narita, International University of Health and Welfare

Division name

Department of Physical Therapy

Zip code

286-8686

Address

4-3 Kozunomori, Narita city, Chiba, Japan

TEL

0476-20-7717

Homepage URL


Email

takekii@iuhw.ac.jp


Sponsor or person

Institute

International University of Health and Welfare

Institute

Department

Personal name

Takeki Ishida


Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics review committee, International University of Health and Welfare

Address

4-3 Kozunomori, Narita city, Chiba, Japan

Tel

0476-20-7708

Email

rinri_md@iuhw.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 04 Month 28 Day

Date of IRB


Anticipated trial start date

2023 Year 05 Month 01 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 04 Month 21 Day

Last modified on

2023 Year 04 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058013